Skip to content

Clinical efficacy of percutaneous acupoint electrical stimulation for the prevention of perioperative urinary retention with LIHR

Clinical efficacy of percutaneous acupoint electrical stimulation for the prevention of perioperative urinary retention with LIHR: a single-center randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000349
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-03-31
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia

Interventions

TEAS Control Group:On the basis of comprehensive intervention, electrical stimulation at 1cm beside the designated acupoint was given
TEAS Intervention Group:On the basis of comprehensive intervention electrical stimulation at designated points was given

Sponsors

Shanghai Putuo Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) According to the "Adult Inguinal Hernia Management Guidelines (2018 Edition)" patients diagnosed with inguinal hernia need to undergo elective LIHR surgery under general anesthesia. (2) Age = 18 years old and = 60 years old with no gender restrictions. (3) Routine admission examinations indicate no significant abnormalities in urinary function and there is no history of severe underlying diseases. (4) Agree to participate in the clinical trial and sign the written informed consent form. All those who meet the above criteria can be included.

Exclusion criteria

Exclusion criteria: (1) Those who are scheduled for concurrent surgery with other surgeons or who are to be converted to open surgery; (2) Patients who develop severe postoperative complications and require intensive care; (3) Patients who are not suitable for transcutaneous electrical acupoint stimulation treatment such as women during menstruation pregnancy or lactation those with a history of pacemaker implantation a history of syncope epilepsy or mental illness or those with skin infections around the designated acupoints; (4) Patients with other urinary system diseases that may cause postoperative urinary retention such as those diagnosed with benign prostatic hyperplasia or prostatic hypertrophy; (5) Those who are participating in other clinical studies within the past six months. Any patient meeting any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Incidence of urinary retention;Urinary patency score;Sense of urination score;Abdominal Symptom scores;Suprapubic bladder area physical examination score;

Secondary

MeasureTime frame
Urination rate at 4h 6h 8h in patients without urinary retention;Residual urine volume of bladder in patients with urinary retention;Length of stay;Comfort VAS scale;Incidence of catheterization;First urination time in patients without urinary retention;Patient quality of life score(QoR-15;

Countries

China

Contacts

Public ContactLuo Xiaorui

Shanghai Putuo Central Hospital

luoxiaoruii@163.com8613355601810

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026